Literature DB >> 10406199

Endotoxemia: an unnecessary but aggravating condition in portal hypertension?

P Sogni, R Moreau, D Lebrec.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10406199     DOI： 10.1016/s0168-8278(99)80275-x

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  3 in total

1.  Influence of Probiotics Administration Before Liver Resection in Patients with Liver Disease: A Randomized Controlled Trial.

Authors:  Edouard Roussel; Carole Brasse-Lagnel; Jean-Jacques Tuech; Helène Montialoux; Eloise Papet; Pauline Tortajada; Soumeya Bekri; Lilian Schwarz
Journal:  World J Surg       Date:  2021-11-26       Impact factor: 3.352

2.  Bacterial translocation to mesenteric lymph nodes increases in chronic portal hypertensive rats.

Authors:  Miguel-Angel Llamas; María-Angeles Aller; Domingo Marquina; María-Paz Nava; Jaime Arias
Journal:  Dig Dis Sci       Date:  2009-10-16       Impact factor: 3.199

3.  Tezosentan, an endothelin receptor antagonist, limits liver injury in endotoxin challenged cirrhotic rats.

Authors:  W Urbanowicz; P Sogni; R Moreau; K A Tazi; E Barriere; O Poirel; A Martin; M C Guimont; D Cazals-Hatem; D Lebrec
Journal:  Gut       Date:  2004-12       Impact factor: 23.059
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.